ATXS vs CCI · rev $706.0K vs P/E 40, rev $2.02B
Astria Therapeutics Inc (ATXS) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported CCI revenue for 2026-06-30 was $2.02B. Net income was $245.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
ATXS currently screens at market cap $382.1M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the ATXS and CCI stock pages for the full models.
Not investment advice.